Establishment Labs Holdings (FRA:3E0) Piotroski F-Score: 4 (As of Jul. 31, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3E0 Establishment Labs Holdings Inc FRA:3E0
72 GF Score
Price €80.62
GF Value €53.91
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Establishment Labs Holdings Piotroski F-Score?

Establishment Labs Holdings FRA:3E0 +0.20% 72 Piotroski F-Score is 4 as of Jul. 31, 2026, which is at its 10-year median of 4.00. GuruFocus rates FRA:3E0 with a GF Score™ of 72/100 and a GF Value™ of €53.91 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 800 Medical Devices & Instruments companies, Establishment Labs Holdings ranks worse than 55.88% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Establishment Labs Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Establishment Labs Holdings's Piotroski F-Score or its related term are showing as below:

FRA:3E0' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 10 years, the highest Piotroski F-Score of Establishment Labs Holdings was 6. The lowest was 2. And the median was 4.

Establishment Labs Holdings  (FRA:3E0) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Establishment Labs Holdings Piotroski F-Score Related Terms


Establishment Labs Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Establishment Labs Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Establishment Labs Holdings Piotroski F-Score Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 2.00 5.00 4.00

Establishment Labs Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 3.00 4.00 4.00

FRA:3E0 vs TMDX, AXGN, ITGR: Piotroski F-Score Comparison

For the Medical Devices subindustry, Establishment Labs Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Piotroski F-Score falls into.


FRA:3E0
72GF Score
Establishment Labs Holdings Inc FRA:3E0
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -14.386 + -9.496 + -2.233 + -11.575 = €-37.7 Mil.
Cash Flow from Operations was -16.259 + -9.585 + -0.138 + -3.728 = €-29.7 Mil.
Revenue was 44.477 + 45.822 + 55.183 + 51.794 = €197.3 Mil.
Gross Profit was 30.581 + 32.117 + 38.884 + 36.62 = €138.2 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(308.362 + 285.822 + 288.739 + 305.021 + 303.647) / 5 = €298.3182 Mil.
Total Assets at the begining of this year (Mar25) was €308.4 Mil.
Long-Term Debt & Capital Lease Obligation was €217.1 Mil.
Total Current Assets was €212.6 Mil.
Total Current Liabilities was €71.9 Mil.
Net Income was -15.961 + -15.03 + -32.977 + -19.157 = €-83.1 Mil.

Revenue was 40.985 + 36.245 + 42.511 + 38.274 = €158.0 Mil.
Gross Profit was 26.882 + 23.171 + 29.12 + 25.722 = €104.9 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(277.691 + 264.847 + 254.699 + 331.224 + 308.362) / 5 = €287.3646 Mil.
Total Assets at the begining of last year (Mar24) was €277.7 Mil.
Long-Term Debt & Capital Lease Obligation was €207.3 Mil.
Total Current Assets was €214.3 Mil.
Total Current Liabilities was €63.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Establishment Labs Holdings's current Net Income (TTM) was -37.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Establishment Labs Holdings's current Cash Flow from Operations (TTM) was -29.7. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-37.69/308.362
=-0.12222647

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-83.125/277.691
=-0.29934351

Establishment Labs Holdings's return on assets of this year was -0.12222647. Establishment Labs Holdings's return on assets of last year was -0.29934351. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Establishment Labs Holdings's current Net Income (TTM) was -37.7. Establishment Labs Holdings's current Cash Flow from Operations (TTM) was -29.7. ==> -29.7 > -37.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=217.114/298.3182
=0.72779334

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=207.332/287.3646
=0.72149458

Establishment Labs Holdings's gearing of this year was 0.72779334. Establishment Labs Holdings's gearing of last year was 0.72149458. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=212.64/71.927
=2.95633072

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=214.319/63.86
=3.35607579

Establishment Labs Holdings's current ratio of this year was 2.95633072. Establishment Labs Holdings's current ratio of last year was 3.35607579. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Establishment Labs Holdings's number of shares in issue this year was 29.947. Establishment Labs Holdings's number of shares in issue last year was 29.476. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=138.202/197.276
=0.70055151

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=104.895/158.015
=0.66382938

Establishment Labs Holdings's gross margin of this year was 0.70055151. Establishment Labs Holdings's gross margin of last year was 0.66382938. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=197.276/308.362
=0.63975457

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=158.015/277.691
=0.56903177

Establishment Labs Holdings's asset turnover of this year was 0.63975457. Establishment Labs Holdings's asset turnover of last year was 0.56903177. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Establishment Labs Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Establishment Labs Holdings (FRA:3E0) has a Piotroski F-Score of 4 as of Jul. 31, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Establishment Labs Holdings and its competitors. This is near median its historical median of 4.00. Over the past decade, Establishment Labs Holdings' Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, Establishment Labs Holdings ranks #447 out of 800 companies in the Medical Devices & Instruments industry, placing it in the top 55.9%.
Is Establishment Labs Holdings' Piotroski F-Score too high?
Establishment Labs Holdings' current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Establishment Labs Holdings' value of 4 is 20% below this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #447 out of 800 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Establishment Labs Holdings has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' Piotroski F-Score compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #447 out of 800 companies for Piotroski F-Score. This places Establishment Labs Holdings in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Establishment Labs Holdings' value of 4 is 20% below this benchmark. Historically, Establishment Labs Holdings' own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Establishment Labs Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 800 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (FRA:3E0) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.91, compared to a current price of €80.62 — trading 49.5% above its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Medical Devices & Instruments industry median of 5.00. Establishment Labs Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Establishment Labs Holdings (FRA:3E0), the current Piotroski F-Score is 4 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Establishment Labs Holdings (FRA:3E0) Overvalued in 2026?

Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued. The current stock price of €80.62 is trading 49.5% above its estimated GF Value™ of €53.91. GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.

Key valuation signals for FRA:3E0:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: €53.91 vs. price of €80.62 (49.5% above fair value)
  • GF Score™: 72/100 with 5 warning signs
  • Industry Position: 20% below the Medical Devices & Instruments median (#447 of 800)

No single metric tells the full story. See the FRA:3E0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Establishment Labs Holdings Business Description

Other Exchanges ESTA:USA3E0:Germany
Address 11401 Century Oaks Terrace, Suite 400, Austin, TX, USA, 78758
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
72GF Score

Get the complete analysis for FRA:3E0

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€80.62
Price
€53.91
GF Value